These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7588946)

  • 1. 18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.
    Grünwald F; Schomburg A; Badali A; Ruhlmann J; Pavics L; Biersack HJ
    Eur J Nucl Med; 1995 Sep; 22(9):1073-7. PubMed ID: 7588946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.
    Colamussi P; Giganti M; Cittanti C; Dovigo L; Trotta F; Tola MR; Tamarozzi R; Lucignani G; Piffanelli A
    Eur J Nucl Med; 1995 Jan; 22(1):17-24. PubMed ID: 7698150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
    Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
    Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.
    Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Eur J Nucl Med; 1996 Jun; 23(6):683-9. PubMed ID: 8662103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cerebral perfusion and cerebrovascular reserve in insulin-dependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide.
    Jiménez-Bonilla JF; Quirce R; Hernández A; Vallina NK; Guede C; Banzo I; Amado JA; Carril JM
    Eur J Nucl Med; 2001 Nov; 28(11):1647-55. PubMed ID: 11702106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
    Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia.
    Pávics L; Grünwald F; Reichmann K; Horn R; Kitschenberg A; Hartmann A; Menzel C; Schomburg AG; Overbeck B; Csernay L; Biersack HJ
    Eur J Nucl Med; 1999 Mar; 26(3):239-45. PubMed ID: 10079314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain single-photon emission tomography with technetium-99m hexamethylpropylene amine oxime in adolescents with initial-stage schizophrenia.
    Batista JF; Galiano MC; Torres LA; Hernández MC; Sosa F; Perera A; Pérez M
    Eur J Nucl Med; 1995 Nov; 22(11):1274-7. PubMed ID: 8575476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.
    Matsuda H; Tsuji S; Shuke N; Sumiya H; Tonami N; Hisada K
    Eur J Nucl Med; 1993 May; 20(5):391-401. PubMed ID: 8519258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of posture-dependent cerebral blood flow in a patient with Takayasu's disease by means of 99mTc-HMPAO brain single photon emission tomography.
    Hayashida K; Nishimura T; Hirose Y; Kaminaga T; Imakita S; Uehara T
    Eur J Nucl Med; 1992; 19(11):987-9. PubMed ID: 1358613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral blood flow in Sjögren's syndrome using 99Tcm-HMPAO brain SPET.
    Lass P; Krajka-Lauer J; Homziuk M; Iwaszkiewicz-Bilikiewicz B; Koseda M; Hebanowski M; Lyczak P
    Nucl Med Commun; 2000 Jan; 21(1):31-5. PubMed ID: 10717899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
    Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
    Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased brain retention of Tc-99m HMPAO following acetazolamide administration.
    Burt RW; Witt RM; Cikrit D; Carter J
    Clin Nucl Med; 1991 Aug; 16(8):568-71. PubMed ID: 1934809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study.
    Shyu WC; Lin JC; Shen CC; Hsu YD; Lee CC; Shiah IS; Tsao WL
    Eur J Nucl Med; 1996 Oct; 23(10):1338-44. PubMed ID: 8781138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement.
    Lin WY; Wang SJ; Yen TC; Lan JL
    J Nucl Med; 1997 Jul; 38(7):1112-5. PubMed ID: 9225800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of morphological changes on perfusion and metabolism in cerebral microangiopathy. A comparison of PET, SPECT, and magnetic resonance imaging findings].
    Sabri O; Hellwig D; Kaiser HJ; Doherty C; Schneider R; Mull M; Willmes von Hinckeldey KW; Büll U; Thron A; Ringelstein EB
    Nuklearmedizin; 1995 Apr; 34(2):50-6. PubMed ID: 7761273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increment of brain temporal perfusion during auditory stimulation. Preliminary study with technetium-99m HMPAO SPET.
    Le Scao Y; Baulieu JL; Robier A; Pourcelot L; Beutter P
    Eur J Nucl Med; 1991; 18(12):981-3. PubMed ID: 1778211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations.
    Colamussi P; Trotta F; Ricci R; Cittanti C; Govoni M; Barbarella G; Giganti M; Bajocchi G; Uccelli L; Trevisan C; Piffanelli A
    Nucl Med Commun; 1997 Mar; 18(3):269-73. PubMed ID: 9106782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease.
    Altehoefer C; Kaiser HJ; Dörr R; Feinendegen C; Beilin I; Uebis R; Buell U
    Eur J Nucl Med; 1992; 19(5):334-42. PubMed ID: 1612095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.